|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net earnings (loss) | |||
| Non-cash items: | |||
| Depreciation | |||
| Depreciation expense | |||
| Amortization | |||
| Amortization – contract asset | |||
| Depreciation and amortization | |||
| Write-down of inventory | |||
| Impairment of intangible assets and property, plant and equipment | |||
| Share-based compensation | |||
| Accretion expense on common shares, retractable | |||
| Accretion expense | |||
| Accretion and revaluation expense on balance of purchase price payable related to the acquisition of the dealership rights | |||
| Accretion expense other | |||
| Accretion expense on convertible debt instruments | |||
| Non-cash issuance of closing fee shares through 2023 Debentures Financing | |||
| Change in fair value of conversion options on convertible debt instruments and interest paid in kind | |||
| Change in fair value of share warrant obligations | |||
| Unrealized foreign exchange loss (gain) | |||
| Finance costs attributable to 2023 Debenture financing | |||
| Net change in non-cash working capital items | |||
| Cash flows used in operating activities | |||
| INVESTING ACTIVITIES | |||
| Acquisition of property, plant and equipment | |||
| Addition to intangible assets | |||
| Disposition of property, plant and equipment | |||
| Government assistance related to property, plant and equipment and intangible assets | |||
| Contact asset, other costs | |||
| Net proceeds from Mirabel battery building sale-leaseback | |||
| Cash flows used in investing activities | |||
| FINANCING ACTIVITIES | |||
| Net change in credit facilities | |||
| Loans on research and development tax credits receivable and subsidies receivable | |||
| Repayment of loans on research and development tax credits and subsidies receivable | |||
| Increase in long-term debt and other debts | |||
| Repayment of long-term debt and other debts | |||
| Repayment of convertible debt instruments | |||
| Payment of lease liabilities | |||
| Proceeds from issuance of convertible debt instruments, net of issuance costs | |||
| Proceeds from issuance of shares through "at-the-market" equity program, net of issuance costs | |||
| Proceeds from the issuance of warrants through the December 2022 Offering | |||
| Proceeds from the issuance of units through the December 2022 Offering - Common Shares, net of issuance costs | |||
| Share redemption | |||
| Proceeds from the 2023 Debentures Financing | |||
| Proceeds from the issuance of shares through exercise of stock options and warrants | |||
| Proceeds from issuance of shares through business combination transaction | |||
| Cash flows from financing activities | |||
| Effect of exchange rate changes on cash held in foreign currency | |||
| Net decrease in cash | |||
| Cash, beginning of year | |||
| Cash, end of year | |||
| Other information on cash flows related to operating activities: | |||
| Income taxes paid | |||
| Interest paid | |||
| Interest paid on obligations under lease liabilities |
Loading...